US 10905768
Heterocyclic degronimers for target protein degradation
granted A61KA61K31/4035A61K31/438
Quick answer
US patent 10905768 (Heterocyclic degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4035, A61K31/438, A61K31/439, A61K31/454